Biochemical analysis and crystallisation of FcγRIIa, the low affinity receptor for IgG

Immunology Letters

Volumn 68, Issue 1, 1999, Pages 17-23

  Powell, M S ^a   Barton, P A ^b   Emmanouilidis, D ^a   Wines, B D ^a   Neumann, G M ^b   Peitersz, G A ^a   Maxwell, K F ^b   Garrett, T P J ^b   Hogarth, P M ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b NONE

Author keywords

Crystallisation; Fc Receptors; Inflammation

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN G;

CHEMICAL ANALYSIS; CONFERENCE PAPER; CRYSTALLIZATION; DIFFRACTION; GLYCOSYLATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN STRUCTURE; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; ANTIBODY AFFINITY; ANTIGENS, CD; BINDING SITES, ANTIBODY; CHO CELLS; CRICETINAE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNOGLOBULIN G; MASS SPECTROMETRY; RECEPTORS, IGG; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 0033519434     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(99)00025-5     Document Type: Conference Paper

References (25)

1. Hulett M.D., Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol. 57:1994;1-127.
2. van de Winkel J.G.J., Capel P.J.A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today. 14:1993;215-221.
3. van de Winkel J.G.J., Anderson C.L. Biology of human immunoglobulin G Fc receptors. J. Leuk. Biol. 49:1991;511-524.
4. Ravetch J.V., Kinet J.-P. Fc receptors. Annu. Rev. Immunol. 9:1991;457-492.
5. Indik Z.H., Park J.-G., Hunter S., Schreiber A.D. The molecular dissection of Fcγ receptor mediated phagocytosis. Blood. 86:1995;4389-4399.
6. Tuijnman W.R., Capel P.J., van de Winkel J.G.J. Human low-affinity IgG receptor FcγRIIa (CD32) introduced into mouse fibroblast mediates phagocytosis of sensitised erythrocytes. Blood. 79:1992;1651-1656.
7. Granziano R.F., Fanger M.W. FcγRI and FcγRII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol. 139:1987;3536-3541.
8. Debets J.M.H., van de Winkel J.G.J., Ceppens J.L., Dieteren I.E.M., Buurman W.A. Cross-linking of both FcγRI and FcγRII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-FcγR interactions. J. Immunol. 144:1990;1304-1310.
9. Williams A.F., Barclay A.N. The immunoglobulin superfamily - domains for cell surface recognition. Annu. Rev. Immunol. 6:1988;381-405.
10. Hibbs M.L., Bonadonna L., Scott B.M., McKenzie I.F.C., Hogarth P.M. Molecular cloning of a human immunoglobulin G Fc receptor. Proc. Natl. Acad. Sci. (USA). 85:1988;2240-2244.
11. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F.C., Hogarth P.M. Identification of the IgG binding site for the low affinity receptor for IgG FcγRII: enhancement and abolition of binding by site-directed mutagenesis. J. Biol. Chem. 269:1994;15287-15293.
12. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F.C., Hogarth P.M. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270:1995;21188-21194.
13. Hogarth P.M., Hulett M.D., Ierino F.L., Tate B., Powell M.S., Brinkworth R.I. Identification of the immunoglobulin binding regions (IBR) of FcγRII and FcεRI. Immunol. Rev. 125:1992;21-35.
14. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex eith Fragment B of Protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry. 20:1981;2361-2370.
15. Burmeister W.P., Gastinel L.N., Simister N.E., Blum M.L., Bjorkman P.J. Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature. 372:1994;336-343.
16. Ierino F.L., Powell M.S., McKenzie I.F.C., Hogarth P.M. Recombinant soluble FcγRII: production, characterisation and inhibition of the Arthus reaction. J. Exp. Med. 178:1993;1617-1628.
17. O'Farrell P.Z., Goodman H.M., O'Farrell P.H. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell. 12:1977;1133-1142.
18. McPherson A. Preparation and Analysis of Protein Crystals. 1982;94-97 John Wiley and Sons, New York.
19. McPherson A. Two approaches to the rapid screening of crystallization conditions. J. Crystal. Growth. 122:1992;161-167.
20. Smith R.I., Coloma M.J., Morrison S.L. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement mediated cytolysis. J. Immunol. 154:1995;2226-2236.
21. Urbanek R. Clinical aspects of IgG subclasses and therapeutic implications. Mongr. Allergy. 23:1988;33-40.
22. Brooks D.G., Qiu W.Q., Luster A.D., Ravetch J.V. Structure and expression of human IgG FcRII. J. Exp. Med. 170:1989;1369-1385.
23. Kuroda K., Geyer H., Geyer R., Doerfler W., Klenk H.D. The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by baculovirus vector. Virology. 174:1990;418-429.
24. Williams P.J., Wormald M.R., Dwek R.A., Rademacher T.W., Parker G.F., Roberts D.R. Characterisation of oligosaccharides from Drosphila melangaster glycoproteins. Biochem. Biophys. Acta. 1075:1991;146-153.
25. Elbein A.D. The role of N-linked oligosaccharides in glycoprotein function. Trends. Biotech. 9:1991;346-352.